Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 27 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 8034334

    Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  2. US 8017135

    Lipid-drug conjugates for local therapy of eye diseases

    The Regents of the University of California · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  3. US 8003622

    Peptide biosynthesis and pain therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  4. US 7998736

    Adoptive immunotherapy with enhanced T lymphocyte survival

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  5. US 7968511

    Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

  6. US 2011142948

    Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy

    BIOLITEC INC [DE] · Granted Jun 16, 2011 · Expires Jun 11, 2031

    granted

  7. US 7939635

    Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted May 10, 2011 · Expires May 5, 2031

    granted

  8. US 7919484

    Combination therapy

    Xenon Pharmaceuticals Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  9. US 7919079

    Cancer immunotherapy compositions and methods of use

    The Regents of the University of California · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  10. US 7871775

    Compositions and methods for the identification, assessment, prevention and therapy of human cancers

    The Board of Regents of the University of Texas System · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  11. US 7825231

    Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  12. US 7815921

    Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy

    Ludwig-Maximilians-Universitat Munchen · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted

  13. US 7807179

    Modified reoviral therapy

    The Board of Regents of the University of Texas System · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  14. US 7799518

    Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer

    The Board of Regents of the University of Texas System · Granted Sep 21, 2010 · Expires Sep 16, 2030

    granted

  15. US 7741304

    Casein kinase 2 antisense therapy

    Regents of the University of Minnesota · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted

  16. US 7713526

    Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

    The Regents of the University of California · Granted May 11, 2010 · Expires May 6, 2030

    granted

  17. US 7709625

    Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy

    The Board of Regents of the University of Texas · Granted May 4, 2010 · Expires Apr 29, 2030

    granted

  18. US 7682607

    Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

    The Regents of the University of California · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted

  19. US 7658923

    Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26

    The Board of Regents of the University of Texas System · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  20. US 7655397

    Selections of genes and methods of using the same for diagnosis and for targeting the therapy of select cancers

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted

  21. US 2009326434

    Anti-Microbial Photodynamic Therapy

    NIFANTIEV NIKOLAY E [RU] · Granted Dec 31, 2009 · Expires Dec 26, 2029

    granted

  22. US 7622556

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  23. US 7622105

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  24. US 7612093

    Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in combination therapy

    United Therapeutics Corporation · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.